The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Belsky Marc since 2016.
The trader's CIK number is 1382629.
At the time of the last reporting, Belsky Marc was the Senior Vice President and CFO of Kezar Life Sciences, Inc.. (stock ticker symbol KZR).
Also see all insider trading activities at Kezar Life Sciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | FPRX | 0 | $0 | 68,792 | $3,185,244 | 68,792 | $564,092 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | KZR | 15,384 | $39,998 | 0 | $0 | 0 | $0 |
| 2019 | KZR | 2,000 | $8,335 | 0 | $0 | 0 | $0 |
1. Five Prime Therapeutics, Inc. (FPRX)
2. Kezar Life Sciences, Inc. (KZR)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-04-22 | FPRX | Option Ex | 34,102 | 10.80 | 368,233 |
| 2016-04-22 | FPRX | Sale | 34,102 | 49.63 | 1,692,652 |
| 2016-04-06 | FPRX | Option Ex | 20,814 | 6.37 | 132,585 |
| 2016-04-06 | FPRX | Sale | 20,814 | 45.04 | 937,462 |
| 2016-03-29 | FPRX | Option Ex | 4,824 | 4.56 | 21,997 |
| 2016-03-30 | FPRX | Option Ex | 9,052 | 4.56 | 41,277 |
| 2016-03-29 | FPRX | Sale | 4,824 | 40.00 | 192,960 |
| 2016-03-30 | FPRX | Sale | 9,052 | 40.01 | 362,170 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-02-04 | KZR | Buy | 15,384 | 2.60 | 39,998 |
| 2019-11-13 | KZR | Buy | 800 | 2.76 | 2,207 |
| 2019-08-20 | KZR | Buy | 200 | 4.42 | 884 |
| 2019-08-09 | KZR | Buy | 500 | 4.82 | 2,410 |
| 2019-07-25 | KZR | Buy | 444 | 5.65 | 2,510 |
| 2019-07-26 | KZR | Buy | 56 | 5.80 | 324 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Belsky Marc (Senior Vice President and CFO of Kezar Life Sciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.